• Je něco špatně v tomto záznamu ?

Five-year survival after post-cardiotomy veno-arterial extracorporeal membrane oxygenation

F. Biancari, A. Perrotti, VG. Ruggieri, G. Mariscalco, M. Dalén, AM. Dell'Aquila, K. Jónsson, S. Ragnarsson, D. Di Perna, K. Bounader, G. Gatti, T. Juvonen, K. Alkhamees, H. Yusuff, A. Loforte, A. Lechiancole, S. Chocron, M. Pol, C. Spadaccio, M....

. 2021 ; 10 (6) : 595-601. [pub] 2021Aug24

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003901

AIMS : Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) support for post-cardiotomy cardiogenic shock (PCS) after adult cardiac surgery is associated with satisfactory hospital survival. However, data on long-term survival of these critically ill patients are scarce. METHODS AND RESULTS: Between January 2010 and March 2018, 665 consecutive patients received VA-ECMO for PCS at 17 cardiac surgery centres and herein we evaluated their 5-year survival. The mean follow-up of this cohort was 1.7 ± 2.7 years (for hospital survivors, 4.6 ± 2.5 years). In this cohort, 240 (36.1%) patients survived to hospital discharge. Five-year survival of all patients was 27.7%. The PC-ECMO score was predictive of 5-year survival in these patients (0 point, 50.9%; 1 point, 44.9%; 2 points, 40.0%; 3 points, 34.7%; 4 points, 21.0%; 5 points, 17.6%; ≥6 points, 10.7%; P < 0.0001). Age was among factors independently associated with late survival, patients >70 years old having a remarkably poor 5-year survival (<60 years: 39.2%; 60-69 years: 29.9%; 70-79 years: 12.3%; ≥80 years: 13.0%, P < 0.0001). Implantation of a ventricular assist device or heart transplant was performed in 3.2% of patients and their 5-year survival was 42.9% (for heart transplant, 63.6%). CONCLUSION : Veno-arterial extracorporeal membrane oxygenation for PCS is associated with satisfactory 5-year survival in young patients without critical pre-ECMO conditions. The use of VA-ECMO for PCS in patients >70 years should be considered only after a judicious scrutiny of patient's life expectancy. Future studies should evaluate whether satisfactory mid-term survival of these patients translates into a good functional outcome. TRIAL REGISTRATION: Clinicaltrials.gov-NCT03508505.

Cardiothoracic Department University Hospital of Udine Udine Italy

Department of Cardiac Surgery Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Department of Cardiac Surgery Sahlgrenska University Hospital Gothenburg Sweden

Department of Cardiothoracic Surgery Golden Jubilee National Hospital Glasgow UK

Department of Cardiothoracic Surgery Henri Mondor University Hospital AP HP Paris Est University Créteil France

Department of Cardiothoracic Surgery Münster University Hospital Münster Germany

Department of Cardiothoracic Surgery University of Lund Lund Sweden

Department of Cardiothoracic Transplantation and Vascular Surgery S Orsola Hospital University of Bologna Bologna Italy

Department of Cardiovascular Surgery Ziekenhuis Oost Limburg Genk Belgium

Department of Intensive Care Medicine and Cardiac Surgery Glenfield Hospital University Hospitals of Leicester Leicester UK

Department of Molecular Medicine and Surgery Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Department of Surgery University of Turku Turku Finland

Department of Thoracic and Cardio Vascular Surgery University Hospital Jean Minjoz Besançon France

Division of Cardiac Surgery Ospedali Riuniti Trieste Italy

Division of Cardiothoracic and Vascular Surgery Pontchaillou University Hospital Rennes France

Division of Cardiothoracic and Vascular Surgery Robert Debré University Hospital Reims France

Heart and Lung Center Helsinki University Hospital Haartmaninkatu 4 P O Box 340 00029 Helsinki Finland

Institute of Clinical and Experimental Medicine Prague Czech Republic

Prince Sultan Cardiac Center Al Hassa Saudi Arabia

Research Unit of Surgery Anesthesiology and Critical Care Faculty of Medicine University of Oulu Oulu Finland

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003901
003      
CZ-PrNML
005      
20220127145739.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ehjacc/zuaa039 $2 doi
035    __
$a (PubMed)33580776
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Biancari, Fausto $u Heart and Lung Center, Helsinki University Hospital, Haartmaninkatu 4 P.O. Box 340, 00029 Helsinki, Finland $u Research Unit of Surgery, Anesthesiology and Critical Care, Faculty of Medicine, University of Oulu, Oulu, Finland $u Department of Surgery, University of Turku, Turku, Finland
245    10
$a Five-year survival after post-cardiotomy veno-arterial extracorporeal membrane oxygenation / $c F. Biancari, A. Perrotti, VG. Ruggieri, G. Mariscalco, M. Dalén, AM. Dell'Aquila, K. Jónsson, S. Ragnarsson, D. Di Perna, K. Bounader, G. Gatti, T. Juvonen, K. Alkhamees, H. Yusuff, A. Loforte, A. Lechiancole, S. Chocron, M. Pol, C. Spadaccio, M. Pettinari, D. De Keyzer, A. Fiore, H. Welp
520    9_
$a AIMS : Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) support for post-cardiotomy cardiogenic shock (PCS) after adult cardiac surgery is associated with satisfactory hospital survival. However, data on long-term survival of these critically ill patients are scarce. METHODS AND RESULTS: Between January 2010 and March 2018, 665 consecutive patients received VA-ECMO for PCS at 17 cardiac surgery centres and herein we evaluated their 5-year survival. The mean follow-up of this cohort was 1.7 ± 2.7 years (for hospital survivors, 4.6 ± 2.5 years). In this cohort, 240 (36.1%) patients survived to hospital discharge. Five-year survival of all patients was 27.7%. The PC-ECMO score was predictive of 5-year survival in these patients (0 point, 50.9%; 1 point, 44.9%; 2 points, 40.0%; 3 points, 34.7%; 4 points, 21.0%; 5 points, 17.6%; ≥6 points, 10.7%; P < 0.0001). Age was among factors independently associated with late survival, patients >70 years old having a remarkably poor 5-year survival (<60 years: 39.2%; 60-69 years: 29.9%; 70-79 years: 12.3%; ≥80 years: 13.0%, P < 0.0001). Implantation of a ventricular assist device or heart transplant was performed in 3.2% of patients and their 5-year survival was 42.9% (for heart transplant, 63.6%). CONCLUSION : Veno-arterial extracorporeal membrane oxygenation for PCS is associated with satisfactory 5-year survival in young patients without critical pre-ECMO conditions. The use of VA-ECMO for PCS in patients >70 years should be considered only after a judicious scrutiny of patient's life expectancy. Future studies should evaluate whether satisfactory mid-term survival of these patients translates into a good functional outcome. TRIAL REGISTRATION: Clinicaltrials.gov-NCT03508505.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    12
$a kardiochirurgické výkony $7 D006348
650    12
$a mimotělní membránová oxygenace $7 D015199
650    12
$a transplantace srdce $7 D016027
650    12
$a podpůrné srdeční systémy $7 D006353
650    _2
$a lidé $7 D006801
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a kardiogenní šok $x etiologie $x terapie $7 D012770
655    _2
$a časopisecké články $7 D016428
700    1_
$a Perrotti, Andrea $u Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France
700    1_
$a Ruggieri, Vito G $u Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France
700    1_
$a Mariscalco, Giovanni $u Department of Intensive Care Medicine and Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, UK
700    1_
$a Dalén, Magnus $u Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden $u Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
700    1_
$a Dell'Aquila, Angelo M $u Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany
700    1_
$a Jónsson, Kristján $u Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
700    1_
$a Ragnarsson, Sigurdur $u Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden
700    1_
$a Di Perna, Dario $u Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France
700    1_
$a Bounader, Karl $u Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France
700    1_
$a Gatti, Giuseppe $u Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy
700    1_
$a Juvonen, Tatu $u Heart and Lung Center, Helsinki University Hospital, Haartmaninkatu 4 P.O. Box 340, 00029 Helsinki, Finland $u Research Unit of Surgery, Anesthesiology and Critical Care, Faculty of Medicine, University of Oulu, Oulu, Finland
700    1_
$a Alkhamees, Khalid $u Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia
700    1_
$a Yusuff, Hakeem $u Department of Intensive Care Medicine and Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, UK
700    1_
$a Loforte, Antonio $u Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy
700    1_
$a Lechiancole, Andrea $u Cardiothoracic Department, University Hospital of Udine, Udine, Italy
700    1_
$a Chocron, Sidney $u Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France
700    1_
$a Pol, Marek $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Spadaccio, Cristiano $u Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, UK
700    1_
$a Pettinari, Matteo $u Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
700    1_
$a De Keyzer, Dieter $u Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
700    1_
$a Fiore, Antonio $u Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Créteil, France
700    1_
$a Welp, Henryk $u Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany
773    0_
$w MED00186154 $t European heart journal. Acute cardiovascular care $x 2048-8734 $g Roč. 10, č. 6 (2021), s. 595-601
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33580776 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145735 $b ABA008
999    __
$a ok $b bmc $g 1751382 $s 1155050
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 6 $d 595-601 $e 2021Aug24 $i 2048-8734 $m European heart journal. Acute cardiovascular care $n Eur Heart J Acute Cardiovasc Care $x MED00186154
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...